Pyrrolidine-fused iminoheterocycles as BACE1 inhibitors for the treatment of Alzheimer's disease

被引：0

作者：

Gilbert, Eric ^{[1
]}

Huang, Chunli ^{[1
]}

Stamford, Andrew ^{[1
]}

Cumming, Jared ^{[1
]}

Greenlee, William ^{[1
]}

Kennedy, Matthew ^{[2
]}

Parker, Eric ^{[2
]}

Kuvelkar, Reshma ^{[3
]}

Cox, Kathleen ^{[5
]}

Voight, Johannes ^{[4
]}

Strickland, Corey ^{[6
]}

Palamanda, Jairam ^{[5
]}

机构：

[1] Merck Res Labs, Dept Chem, Rahway, NJ 07065 USA

[2] Merck Res Labs, Dept CNS Biol, Kenilworth, NJ 07033 USA

[3] Merck Res Labs, Dept In Vitro Sci, Kenilworth, NJ 07033 USA

[4] Merck Res Labs, Dept Chem Modeling & Informat, Rahway, NJ 07065 USA

[5] Merck Res Labs, Dept Exploratory Drug Metab, Kenilworth, NJ 07033 USA

[6] Merck Res Labs, Dept Struct Chem, Kenilworth, NJ 07033 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2012年 / 244卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

101-MEDI

引用

页数：1

共 50 条

[41] Targeting the β secretase BACE1 for Alzheimer's disease therapy
Yan, Riqiang
Vassar, Robert
LANCET NEUROLOGY, 2014, 13 (03): : 319 - 329
[42] BACE1 inhibition as a therapeutic strategy for Alzheimer's disease
Vassar, Robert
Journal of Sport and Health Science, 2016, 5 (04) : 388 - 390
[43] BACE1: A Key Regulator in Alzheimer's Disease Progression and Current Development of its Inhibitors
Patel, Smith
Bansoad, Ankush Vardhaman
Singh, Rakesh
Khatik, Gopal L.
CURRENT NEUROPHARMACOLOGY, 2022, 20 (06) : 1174 - 1193
[44] BACE1 expression and activity: Relevance in Alzheimer's disease
Zacchetti, Daniele
Chieregatti, Evelina
Bettegazzi, Barbara
Mihailovich, Marija
Sousa, Vitor Lino
Grohovaz, Fabio
Meldolesi, Jacopo
NEURODEGENERATIVE DISEASES, 2007, 4 (2-3) : 117 - 126
[45] Design and optimization of heterocyclic 4-azaxanthenes as potent and selective inhibitors of BACE1 for the treatment of Alzheimer's disease
Marx, Isaac E.
Chen, Kui
Cheng, Alan C.
Dineen, Thomas A.
Epstein, Oleg
Esmay, Joel
Hickman, Dean
Kreiman, Chuck E.
Wahl, Robert C.
Wen, Paul H.
Weiss, Matthew M.
Whittington, Douglas A.
Wood, Stephen
Fremeau, Robert T.
White, Ryan D.
Patel, Vinod F.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
[46] Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer's Disease
Yuan, Jing
Venkatraman, Shankar
Zheng, Yajun
McKeever, Brian M.
Dillard, Lawrence W.
Singh, Suresh B.
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (11) : 4156 - 4180
[47] BACE1 and BACE2: exclusion of allele association with Alzheimer's disease
Giannakopoulos, P
Herrmann, F
Gold, G
Bouras, C
Mulligan, R
Duriaux-Sail, G
Michon, A
Antonarakis, SE
Blouin, JL
EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 267 - 267
[48] Development of an efficient structure-based drug discovery platform for BACE1 Inhibitors for the treatment of Alzheimer's Disease
Yen, Yu-Chen
Kammeyer, Annalissa
Jensen, Katherine C.
Ghosh, Arun K.
Mesecar, Andrew D.
FASEB JOURNAL, 2016, 30
[49] Alzheimer disease: BACE1 branches out
Charlotte Schubert
Nature Medicine, 2006, 12 : 1123 - 1123
[50] Alzheimer disease: BACE1 branches out
Schubert, Charlotte
NATURE MEDICINE, 2006, 12 (10) : 1123 - 1123

← 1 2 3 4 5 →